THIRUVANANTHAPURAM: In a major breakthrough, doctors at Sree Chitra Tirunal Institute for Medical Sciences and Technology ...
Morning Overview on MSN
A new two-pill combo just slashed LDL cholesterol by 48.6% in a phase 3 trial — the sharpest drop ever logged without adding a statin to the mix
For the roughly 30 million American adults who have been told their cholesterol is too high but cannot stomach a statin, the ...
If it continues to work in further studies, a gene therapy in development could eliminate the need for daily pills or regular ...
Regular follow-up calls from a pharmacist can help people lower their "bad" (LDL) cholesterol by reminding them to take their ...
An experimental gene-editing therapy that aims to lower bad cholesterol for the long-term after a single infusion is off to a ...
“Consuming foods high in sugar, such as pastries, can significantly impact your cholesterol profile, primarily by altering ...
A one-time gene-editing infusion kept cholesterol levels low for a year, offering a potential new approach to preventing ...
Drugmaker Eli Lilly is testing a new experimental drug that could be a game changer in treating high cholesterol, it said.
Have you been diagnosed with high cholesterol levels? Beware! your heart could be at risk - here are 7 fruits that you need ...
Eli Lilly is laying the groundwork for a phase 2 trial of the lipid-lowering gene editor it acquired from Verve Therapeutics, with the candidate now showing strong and consistent cholesterol ...
One and done? Pharma giant Eli Lilly announced Monday that its gene-editing therapy can reduce LDL (“bad”) cholesterol by up ...
Early CRISPR-based cholesterol therapy shows striking LDL reduction, but experts warn that safety, durability and off-target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results